Stem cells for murine interstitial cells of Cajal suppress cellular immunity and colitis via prostaglandin E2 secretion

Gastroenterology

Volumn 148, Issue 5, 2015, Pages 978-990

  Dave, Maneesh ^a   Hayashi, Yujiro ^a,b   Gajdos, Gabriella B ^a,b   Smyrk, Thomas C ^a   Svingen, Phyllis A ^a   Kvasha, Sergiy M ^a,b   Lorincz, Andrea ^a,b   Dong, Haidong ^a   Faubion, William A ^a   Ordog, Tamas ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

IBD; ICC; Immunosuppression

Indexed keywords

PROGRAMMED DEATH 1 RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA; DEXTRAN SULFATE; DNA BINDING PROTEIN; GENETIC MARKER; HOMEODOMAIN PROTEIN; RAG-1 PROTEIN; RAG2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL TRANSFER; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE ACTIVITY SCORE; DISEASE SEVERITY; EXPERIMENTAL COLITIS; HORMONE RELEASE; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; INTERSTITIAL CELL OF CAJAL; INTERSTITIAL STEM CELL OF CAJAL; INTESTINAL STEM CELL; INTESTINE FLORA; INVESTIGATIVE PROCEDURES; MESENCHYMAL STEM CELL; MIXED LYMPHOCYTE REACTION; MOUSE; MURINAE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; WEIGHT REDUCTION; ADOPTIVE TRANSFER; ANIMAL; C57BL MOUSE; CELL CULTURE; CHEMICALLY INDUCED; COLITIS; COLON; DEFICIENCY; GENE EXPRESSION PROFILING; GENETIC MARKER; GENETICS; IMMUNOCOMPROMIZED PATIENT; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; SECRETION (PROCESS); STEM CELL TRANSPLANTATION; TIME; TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; COLITIS; COLON; DEXTRAN SULFATE; DINOPROSTONE; DNA-BINDING PROTEINS; GENE EXPRESSION PROFILING; GENETIC MARKERS; HOMEODOMAIN PROTEINS; IMMUNITY, CELLULAR; IMMUNOCOMPROMISED HOST; INTERSTITIAL CELLS OF CAJAL; LYMPHOCYTE ACTIVATION; MICE, INBRED C57BL; MICE, KNOCKOUT; STEM CELL TRANSPLANTATION; T-LYMPHOCYTES; TIME FACTORS;

EID: 84928699966     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2015.01.036     Document Type: Article

References (37)

1. C.G. Loftus, E.V. Loftus Jr., and W.S. Harmsen Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000 Inflamm Bowel Dis 13 2007 254 261
2. M. Dave, K.A. Papadakis, and W.A. Faubion Jr. Immunology of inflammatory bowel disease and molecular targets for biologics Gastroenterol Clin N Am 43 2014 405 424
3. K. English Mechanisms of mesenchymal stromal cell immunomodulation Immunol Cell Biol 91 2013 19 26
4. M.A. Gonzalez, E. Gonzalez-Rey, and L. Rico Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses Gastroenterology 136 2009 978 989
5. H.S. Kim, T.H. Shin, and B.C. Lee Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2 Gastroenterology 145 2013 1392 1403 e1391-e1398
6. P. Bianco, X. Cao, and P.S. Frenette The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine Nat Med 19 2013 35 42
7. M. Dominici, K. Le Blanc, and I. Mueller Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement Cytotherapy 8 2006 315 317
8. K. Nemeth, A. Leelahavanichkul, and P.S. Yuen Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production Nat Med 15 2009 42 49
9. A. Augello, R. Tasso, and S.M. Negrini Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway Eur J Immunol 35 2005 1482 1490
10. C. Wang, J. Chen, and L. Sun TGF-beta signaling-dependent alleviation of dextran sulfate sodium-induced colitis by mesenchymal stem cell transplantation Mol Biol Rep 41 2014 4977 4983
11. K. English, J.M. Ryan, and L. Tobin Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells Clin Exp Immunol 156 2009 149 160
12. K.M. Sanders, S.M. Ward, and S.D. Koh Interstitial cells: regulators of smooth muscle function Physiol Rev 94 2014 859 907
13. J.D. Huizinga, N. Zarate, and G. Farrugia Physiology, injury, and recovery of interstitial cells of Cajal: basic and clinical science Gastroenterology 137 2009 1548 1556
14. T. Ordog Cellular pathogenesis of gastroparesis H.P. Parkman, R.W. McCallum, Gastroparesis: pathophysiology, presentation, diagnosis, and treatment 2012 Springer New York 47 64
15. A. Lorincz, D. Redelman, and V.J. Horvath Progenitors of interstitial cells of cajal in the postnatal murine stomach Gastroenterology 134 2008 1083 1093
16. M.R. Bardsley, V.J. Horvath, and D.T. Asuzu Kitlow stem cells cause resistance to Kit/platelet-derived growth factor alpha inhibitors in murine gastrointestinal stromal tumors Gastroenterology 139 2010 942 952
17. S. Reagan-Shaw, M. Nihal, and N. Ahmad Dose translation from animal to human studies revisited Faseb J 22 2008 659 661
18. W.A. Faubion, Y.P. De Jong, and A.A. Molina Colitis is associated with thymic destruction attenuating CD4+25+ regulatory T cells in the periphery Gastroenterology 126 2004 1759 1770
19. S. Wirtz, C. Neufert, and B. Weigmann Chemically induced mouse models of intestinal inflammation Nat Protoc 2 2007 541 546
20. D. Ramskold, E.T. Wang, and C.B. Burge An abundance of ubiquitously expressed genes revealed by tissue transcriptome sequence data PLoS Comput Biol 5 2009 e1000598
21. J.D. Fontenot, J.P. Rasmussen, and L.M. Williams Regulatory T cell lineage specification by the forkhead transcription factor foxp3 Immunity 22 2005 329 341
22. Y. Xiong, S. Khanna, and A.L. Grzenda Polycomb antagonizes p300/CREB-binding protein-associated factor to silence FOXP3 in a Kruppel-like factor-dependent manner J Biol Chem 287 2012 34372 34385
23. A. Chaudhry, R.M. Samstein, and P. Treuting Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation Immunity 34 2011 566 578
24. S. Wislet-Gendebien, E. Laudet, and V. Neirinckx Mesenchymal stem cells and neural crest stem cells from adult bone marrow: characterization of their surprising similarities and differences Cell Mol Life Sci 69 2012 2593 2608
25. M.R. Walker, S.L. Brown, and T.E. Riehl Growth factor regulation of prostaglandin-endoperoxide synthase 2 (Ptgs2) expression in colonic mesenchymal stem cells J Biol Chem 285 2010 5026 5039
26. H. Chen, T. Ordog, and J. Chen Differential gene expression in functional classes of interstitial cells of Cajal in murine small intestine Physiol Genomics 31 2007 492 509
27. G.M. Forbes, M.J. Sturm, and R.W. Leong A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy Clin Gastroenterol Hepatol 12 2014 64 71
28. V. Sreeramkumar, M. Fresno, and N. Cuesta Prostaglandin E2 and T cells: friends or foes? Immunol Cell Biol 90 2012 579 586
29. V. Kolenko, P. Rayman, and B. Roy Downregulation of JAK3 protein levels in T lymphocytes by prostaglandin E2 and other cyclic adenosine monophosphate-elevating agents: impact on interleukin-2 receptor signaling pathway Blood 93 1999 2308 2318
30. W.L. Farrar, S.W. Evans, and U.R. Rapp Effects of anti-proliferative cyclic AMP on interleukin 2-stimulated gene expression J Immunol 139 1987 2075 2080
31. D. Mary, C. Aussel, and B. Ferrua Regulation of interleukin 2 synthesis by cAMP in human T cells J Immunol 139 1987 1179 1184
32. K. Kabashima, T. Saji, and T. Murata The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut J Clin Invest 109 2002 883 893
33. E. Gonzalez-Rey, P. Anderson, and M.A. Gonzalez Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis Gut 58 2009 929 939
34. T. Yamada, M. Yoshikawa, and M. Takaki In vitro functional gut-like organ formation from mouse embryonic stem cells Stem Cells 20 2002 41 49
35. T. Ueda, T. Yamada, and D. Hokuto Generation of functional gut-like organ from mouse induced pluripotent stem cells Biochem Biophys Res Commun 391 2010 38 42
36. J.A. Bradley, E.M. Bolton, and R.A. Pedersen Stem cell medicine encounters the immune system Nat Rev Immunol 2 2002 859 871
37. Z.S. Scheiner, S. Talib, and E.G. Feigal The potential for immunogenicity of autologous induced pluripotent stem cell-derived therapies J Biol Chem 289 2014 4571 4577